KPV KPV PRODUCT IMAGE
HPLC VERIFIED COA SUPPLIED ≥98.5% PURITY
— Healing & Repair

KPV Lys-Pro-Val Tripeptide

For in vitro research use only. KPV is not for human or veterinary consumption, diagnosis, treatment, or prevention of any condition.

KPV is a naturally occurring tripeptide consisting of the amino acids lysine, proline, and valine. It corresponds to the C-terminal sequence of alpha-melanocyte-stimulating hormone (α-MSH). Preclinical studies have investigated how KPV interacts with inflammatory signalling pathways, particularly NF-κB-mediated cytokine expression, and its potential role in tissue-repair and mucosal-healing models.

CAS Number
13147-97-2
Molecular Formula
C₁₄H₂₅N₃O₄
HPLC Purity
≥98.5% (batch-verified)
Form
Lyophilised powder
Storage
2–8°C, desiccated, protected from light
Classification
Research reagent — in vitro use only

Research overview

KPV (Lys-Pro-Val) is a tripeptide corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (α-MSH). It is a research-grade synthetic peptide supplied as a lyophilised powder. Preclinical studies have examined its interaction with the melanocortin-1 receptor (MC1R) and its downstream effects on the NF-κB inflammatory signalling pathway. Cell-based models have investigated how KPV affects the production of pro-inflammatory cytokines including TNF-α and IL-6. Mucosal healing studies in rodent models have examined its potential relevance to intestinal tissue-repair processes. For research use only. Not for human or veterinary consumption.

Summary paraphrased from the peer-reviewed preclinical literature. Full citations will be available in the research library. For in vitro research use only.

Compound specifications

Common nameKPV
Full nameLys-Pro-Val Tripeptide
CAS number13147-97-2
Molecular formulaC₁₄H₂₅N₃O₄
Molecular weight299.4 g/mol
SequenceLys-Pro-Val
HPLC purity≥98.5% (batch-verified)
AppearanceWhite to off-white lyophilised powder
SolubilityBacteriostatic water, sterile saline
Storage (lyophilised)2–8°C, protected from light
Storage (reconstituted)2–8°C, up to 28 days
Supplied as10mg

Batch testing and certificate of analysis

Every batch of KPV is third-party HPLC-tested prior to dispatch. A batch-specific certificate of analysis documenting HPLC purity, mass spectrometry confirmation, and appearance is supplied with every order.

Previous batch CoAs are archived in the CoA library. For batch-specific CoA requests prior to purchase, contact veloxpeps@gmail.com.

Frequently Asked Research-Use Questions

What purity is Velox Peptides KPV?
KPV is supplied at ≥98.5% HPLC-verified purity. A certificate of analysis is provided with every order. Every batch is third-party tested before dispatch.
How is KPV supplied and reconstituted for research use?
KPV is supplied as a lyophilised powder in sterile single-use vials. For in vitro research use, reconstitution is performed with bacteriostatic water. See the reconstitution calculator for volume calculations based on required concentration.
What is KPV used for in preclinical research?
KPV is studied in the peer-reviewed literature across the pathways described in the research overview above. Velox Peptides supplies KPV strictly as a research reagent for in vitro use by qualified researchers. It is not a medicinal product and is not for human or veterinary consumption.
What is the CAS number for KPV?
The CAS registry number for KPV is 13147-97-2. This identifier is listed on every batch certificate of analysis supplied with orders.

Compliance notice

For in vitro research use only. KPV is supplied solely as a research reagent for qualified professionals conducting in vitro or animal-model studies. It is not a medicinal product within the meaning of the Human Medicines Regulations 2012. It has not been evaluated by the MHRA or FDA. It is not intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale.

Compliance statement. Velox Peptides supplies research reagents for in vitro use by qualified researchers. Every compound is sold strictly as a research reagent. No product is a medicinal product within the meaning of the Human Medicines Regulations 2012. No product has been evaluated by the MHRA or FDA. No product is intended for human or veterinary consumption, diagnosis, treatment, cure, or prevention of any condition. Any use outside lawful scientific research is outside the scope of sale. See our Research Use Policy and MHRA Statement.